Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-051790

Chief Executive Officer sold 7,800 shares at an average $39.81 ($310,479)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-09-18 Sale −3,900 $39.62 $154,518 62,578 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-09-19 Sale −3,900 $39.99 $155,961 58,678 I: show line 2 in the form
Open-market sales · 7,800 sh · avg $39.81 · $310,479
Loading xslF345X03/doc4.xml…